Literature DB >> 25641190

Discovery of a series of aromatic lactones as ALDH1/2-directed inhibitors.

Cameron D Buchman1, Krishna K Mahalingan1, Thomas D Hurley2.   

Abstract

In humans, the aldehyde dehydrogenase superfamily consists of 19 isoenzymes which mostly catalyze the NAD(P)(+)-dependent oxidation of aldehydes. Many of these isoenzymes have overlapping substrate specificities and therefore their potential physiological functions may overlap. Thus the development of new isoenzyme-selective probes would be able to better delineate the function of a single isoenzyme and its individual contribution to the metabolism of a particular substrate. This specific study was designed to find a novel modulator of ALDH2, a mitochondrial ALDH isoenzyme most well-known for its role in acetaldehyde oxidation. 53 compounds were initially identified to modulate the activity of ALDH2 by a high-throughput esterase screen from a library of 63,000 compounds. Of these initial 53 compounds, 12 were found to also modulate the oxidation of propionaldehyde by ALDH2. Single concentration measurements at 10μM compound were performed using ALDH1A1, ALDH1A2, ALDH1A3, ALDH2, ALDH1B1, ALDH3A1, ALDH4A1, and/or ALDH5A1 to determine the selectivity of these 12 compounds toward ALDH2. Four of the twelve compounds shared an aromatic lactone structure and were found to be potent inhibitors of the ALDH1/2 isoenzymes, but have no inhibitory effect on ALDH3A1, ALDH4A1 or ALDH5A1. Two of the aromatic lactones show selectivity within the ALDH1/2 class, and one appears to be selective for ALDH2 compared to all other isoenzymes tested.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Aldehyde dehydrogenase; High-throughput screening; Inhibition

Mesh:

Substances:

Year:  2015        PMID: 25641190      PMCID: PMC4414788          DOI: 10.1016/j.cbi.2014.12.038

Source DB:  PubMed          Journal:  Chem Biol Interact        ISSN: 0009-2797            Impact factor:   5.192


  35 in total

Review 1.  Role of aldehyde dehydrogenases in endogenous and xenobiotic metabolism.

Authors:  V Vasiliou; A Pappa; D R Petersen
Journal:  Chem Biol Interact       Date:  2000-12-01       Impact factor: 5.192

2.  Development of selective inhibitors for human aldehyde dehydrogenase 3A1 (ALDH3A1) for the enhancement of cyclophosphamide cytotoxicity.

Authors:  Bibek Parajuli; Taxiarchis M Georgiadis; Melissa L Fishel; Thomas D Hurley
Journal:  Chembiochem       Date:  2014-03-21       Impact factor: 3.164

3.  Aldehyde dehydrogenase 1B1: molecular cloning and characterization of a novel mitochondrial acetaldehyde-metabolizing enzyme.

Authors:  Dimitrios Stagos; Ying Chen; Chad Brocker; Elizabeth Donald; Brian C Jackson; David J Orlicky; David C Thompson; Vasilis Vasiliou
Journal:  Drug Metab Dispos       Date:  2010-07-08       Impact factor: 3.922

Review 4.  Polymorphisms of human aldehyde dehydrogenases. Consequences for drug metabolism and disease.

Authors:  V Vasiliou; A Pappa
Journal:  Pharmacology       Date:  2000-09       Impact factor: 2.547

Review 5.  Eukaryotic aldehyde dehydrogenase (ALDH) genes: human polymorphisms, and recommended nomenclature based on divergent evolution and chromosomal mapping.

Authors:  V Vasiliou; A Bairoch; K F Tipton; D W Nebert
Journal:  Pharmacogenetics       Date:  1999-08

6.  Multiple conformations of NAD and NADH when bound to human cytosolic and mitochondrial aldehyde dehydrogenase.

Authors:  Philip K Hammen; Abdellah Allali-Hassani; Klaas Hallenga; Thomas D Hurley; Henry Weiner
Journal:  Biochemistry       Date:  2002-06-04       Impact factor: 3.162

Review 7.  Families of retinoid dehydrogenases regulating vitamin A function: production of visual pigment and retinoic acid.

Authors:  G Duester
Journal:  Eur J Biochem       Date:  2000-07

8.  Aldehyde dehydrogenase 1B1 (ALDH1B1) is a potential biomarker for human colon cancer.

Authors:  Ying Chen; David J Orlicky; Akiko Matsumoto; Surendra Singh; David C Thompson; Vasilis Vasiliou
Journal:  Biochem Biophys Res Commun       Date:  2011-01-07       Impact factor: 3.575

9.  Reactions of formaldehyde plus acetaldehyde with deoxyguanosine and DNA: formation of cyclic deoxyguanosine adducts and formaldehyde cross-links.

Authors:  Guang Cheng; Yongli Shi; Shana J Sturla; John R Jalas; Edward J McIntee; Peter W Villalta; Mingyao Wang; Stephen S Hecht
Journal:  Chem Res Toxicol       Date:  2003-02       Impact factor: 3.739

10.  Development of selective inhibitors for aldehyde dehydrogenases based on substituted indole-2,3-diones.

Authors:  Ann C Kimble-Hill; Bibek Parajuli; Che-Hong Chen; Daria Mochly-Rosen; Thomas D Hurley
Journal:  J Med Chem       Date:  2014-01-31       Impact factor: 7.446

View more
  3 in total

1.  Inhibition of the Aldehyde Dehydrogenase 1/2 Family by Psoralen and Coumarin Derivatives.

Authors:  Cameron D Buchman; Thomas D Hurley
Journal:  J Med Chem       Date:  2017-03-06       Impact factor: 7.446

Review 2.  Update of ALDH as a Potential Biomarker and Therapeutic Target for AML.

Authors:  Xiangchou Yang; Rongxin Yao; Hong Wang
Journal:  Biomed Res Int       Date:  2018-01-03       Impact factor: 3.411

3.  Bone marrow stromal cells induce an ALDH+ stem cell-like phenotype and enhance therapy resistance in AML through a TGF-β-p38-ALDH2 pathway.

Authors:  Bin Yuan; Fouad El Dana; Stanley Ly; Yuanqing Yan; Vivian Ruvolo; Elizabeth J Shpall; Marina Konopleva; Michael Andreeff; Venkata Lokesh Battula
Journal:  PLoS One       Date:  2020-11-30       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.